| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| The dependence of this increased cell proliferation on GR activation by DEX and the sustained activation of ERK was examined using RU 486 ( a GR inhibitor ) and U 0126 ( a MEK inhibitor ) . ^^^ |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| The purpose of the present study was to investigate whether 5 hydroxytryptamine ( 5 HT , serotonin ) affects migration of vascular endothelial cells . 5 HT significantly enhanced migration of human aortic endothelial cells ( HAECs ) , and this enhancement was completely inhibited by GR 55562 , a 5 HT 1 receptor antagonist , and fluoxetine , a 5 HT transporter inhibitor , but was not affected by ketanserin , a 5 HT 2 receptor antagonist . 5 HT stimulation increased RhoA and ERK activity of HAECs , and inhibitors of RhoA ( Y 27632 and H 1152 ) and inhibitors of MEK ( U 0126 and PD 98059 ) abolished the 5 HT induced increase in migration velocity . ^^^ |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| The mitogen activated protein kinases ERK ( extracellular signal regulated kinase ) , JNK ( c Jun N terminal kinase ) , and p 38 phosphorylate and activate transcription factors that promote proliferative and inflammatory responses , whereas glucocorticoid receptor ( GR ) activation inhibits cell growth and inflammation . ^^^ |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| Because BAG 1 attenuates glucocorticoid receptor ( GR ) nuclear translocation , activates ERK ( extracellular signal regulated kinase ) MAP ( mitogen activated protein ) kinases , and potentiates anti apoptotic functions of BCL 2 , extensive additional studies were undertaken . ^^^ |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| ERK 8 down regulates transactivation of the glucocorticoid receptor through Hic 5 . ^^^ |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P04150 and P28482 |
Pubmed |
SVM Score :0.0 |
| NA |
|